West Nile 25A virus infection of B-cell-deficient (μMT) mice: Characterization of neuroinvasiveness and pseudoreversion of the viral envelope protein

Journal of General Virology

Volumn 89, Issue 3, 2008, Pages 627-635

  Chambers, Thomas J ^a   Droll, Deborah A ^a   Walton, Andrew H ^a   Schwartz, Julie ^a   Wold, William S M ^a   Nickells, Janice ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; GLYCOPROTEIN E; SERINE; TYROSINE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL DEFICIENT MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; ENCEPHALITIS; GENETIC CONSERVATION; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; REVERTANT; SEQUENCE ANALYSIS; SURVIVAL RATE; VIREMIA; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; VIRUS VIRULENCE; WEST NILE 25A VIRUS; WEST NILE FLAVIVIRUS; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; B LYMPHOCYTE; BRAIN; C57BL MOUSE; CERCOPITHECUS; CHEMICAL STRUCTURE; CHEMISTRY; DISEASE MODEL; DNA SEQUENCE; GENETICS; GLYCOSYLATION; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MORTALITY; MUTATION; PATHOGENICITY; PATHOLOGY; VERO CELL; VIROLOGY; VIRULENCE; VIRUS ENCEPHALITIS;

MUS; WEST NILE VIRUS;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; BRAIN; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; GLYCOSYLATION; HUMANS; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIREMIA; VIRULENCE; WEST NILE FEVER; WEST NILE VIRUS;

EID: 42449102299     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83297-0     Document Type: Article

References (41)

1. Beasley, D. W., Li, L., Suderman, M. T. & Barrett, A. D. (2001). West Nile virus strains differ in mouse neurovirulence and binding to mouse or human brain membrane receptor preparations. Ann N Y Acad Sci 951, 332-335.
2. Beasley, D. W., Li, L., Suderman, M. T. & Barrett, A. D. (2002). Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296, 17-23.
3. Beasley, D. W. C., Whiteman, M. C., Zhang, S., Huang, C. Y.-H., Schneider, B. S., Smith, D. R., Gromowski, G. D., Higgs, S., Kinney, R. M. & Barrett, A. D. T. (2005). Envelope protein glycosylation status influences Mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol 79, 8339-8347.
4. Ben-Nathan, D., Lustig, S. & Feuerstein, G. (1989). The influence of cold or isolation stress on neuroinvasiveness and virulence of an attenuated variant of West Nile virus. Arch Virol 109, 1-10.
5. Ben-Nathan, D., Huitingb, I., Lustig, S., van Rooijen, N. & Kobiler, D. (1996). West Nile virus neuroinvasion and epcephalitis induced by macrophage depletion in mice. Arch Virol 141, 459-469.
6. Ben-Nathan, D., Lustig, S., Tam, G., Robinzon, S., Segal, S. & Rager-Zisman, B. (2003). Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 188, 5-12.
7. Berthet, F. X., Zeller, H. G., Drouet M. T., Rauzier, J., Digoutte, J. P. & Deubel, V. (1997). Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J Gen Virol 78, 2293-2297.
8. Bondre, V. P., Jadi, R. S., Mishra, A. C., Yergolkar, P. N. & Arankalle, V. A. (2007). West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol 88, 875-884.
9. Brandriss, M. W., Schlesinger, J. J., Walsh, E. E. & Briselli, M. (1986). Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue, 2 viruses. J Gen Virol 67, 229-234.
10. Broom, A. K., Wallace, M. J., Mackenzie, J. S., Smith, D. W. & Hall, R. A. (2000). Immunisation with gamma globulin to Murray Valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against Australian encephalitis: evaluation in a mouse model. J Med Virol 61, 259-265.
11. Burke, S. D. & Monath, T. P. (2001). Flaviviruses. In Fields Virology, Vol. 1, 4th edn, pp. 1043-125. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
12. Burt, F. J., Grobbelaar, A. A., Leman, P. A., Anthony, F. S., Gibson, G. V. & Swanepoel, R. (2002). Phylogenetic relationships of Southern African West Nile virus isolates. Emerg Infect Dis 8, 820-826.
13. Chambers, T. J., Halevy, M., Nestorowicz, A., Rice, C. M. & Lustig, S. (1998). West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. J Gen Virol 79, 2375-2380.
14. Davis, C. T., Beasley, D. W., Guzman, H., Siirin, M., Parsons, R. E., Tesh, R. B. & Barrett, A. D. (2004). Emergence of attenuated West Nile virus variants in Texas, 2003. Virology 330, 342-350.
15. Diamond, M. S., Shrestha, B., Marri, A., Mahan, D. & Engle, M. (2003). B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77, 2578-2386.
16. Goldblum, N., Strek, V. V. & Padersky, B. (1954). West Nile fever: the clinical features of the disease and isolation of West Nile from the blood of nine human cases. Am J Hyg 59, 89-103.
17. Halevy, M., Akov, Y., Ben-Nathan, B., Kobiler, D., Lachmi, B. & Lustig, S. (1994). Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch Virol 137, 355-370.
18. Katz, Y., Lustig, S., Ben-Shlomo, I., Kobiler, D. & Ben-Nathan, D. (2002). Inhalation anesthetic-induced neuroinvasion by an attenuated strain of West Nile virus in mice. J Med Virol 66, 576-580.
19. Kimura-Kuroda, J. & Yasui, K. (1988). Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol 141, 3606-3610.
20. Kobiler, D., Lustig, S., Gozes, Y., Ben-Nathan, D. & Akov, Y. (1989). Sodium dodecylsulphate induces a breach in the blood-brain barrier and enables a West Nile virus variant to penetrate into mouse brain. Brain Res 496, 314-316.
21. Lanciotti, R. S., Roehrig, J. T., Deubel, V., Smith, J., Parker, M., Steele, K., Crise, B., Volpe, K. E., Crabtree, M. B. & other authors (1999). Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286, 2333-2337.
22. Lee, E., Hall, R. A. & Lobigs, M. (2004). Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol 78, 8271-8280.
23. Lustig, S., Danenberg, H. D., Kafri, Y., Kobiler, D. & Ben-Nathan, D. (1992). Viral neuroinvasion and encephalitis induced by lipopolysaccharide and its mediators. J Exp Med 176, 707-712.
24. Lustig, S., Olshevsky, U., Ben-Nathan, D., Lachmi, B. E., Malkinson, M., Kobiler, D. & Halevy, M. (2000). A live attenuated West Nile virus strain as a potential veterinary vaccine. Viral Immunol 13, 401-410.
25. Mathews, J. H. & Roehrig, J. T. (1984). Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol 132, 1533-1537.
26. Nybakken, G. E., Nelson, C. A., Chen, B. R., Diamond, M. S. & Fremont D. H. (2006). Crystal structure of the West Nile virus envelope glycoprotein. J Virol 80, 11467-11474.
27. Petersen, L. R. & Roehrig, J. T. (2001). West Nile virus: a reemerging global pathogen. Emerg Infect Dis 7, 611-614.
28. Phillpotts, R. J., Stephenson, J. R. & Porterfield, J. S. (1987). Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virus: brief report. Arch Virol 93, 295-301.
29. Price, W. H. & O'Leary, W. (1967). Geographic variation in the antigenic character of West Nile virus. Am J Epidemiol 85, 84-86.
30. Rappole, J. H., Derrickson, S. R. & Hubalek Z. (2000). Migratory birds and spread of West Nile virus in the western hemisphere. Emerg Infect Dis 6, 319-328.
31. Roehrig, J. T., Staudinger, L. A., Hunt, A. R., Mathews, J. H. & Blair, C. D. (2001). Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann N Y Acad Sci 951, 286-297.
32. Roehrig, J. T., Layton, M., Smith, P., Campbell, G. L., Nasci, R. & Lanciotti, R. S. (2002). The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol 267, 223-240.
33. Scherret J. H., Poidinger, M., Mackenzie, J. S., Broom, A. K., Deubel, V., Lipkin, W. I., Briese, T., Gould, E. A. & Hall, R. A. (2001). The relationships between West Nile and Kunjin viruses. Emerg Infect Dis 7, 697-705.
34. Scherret J. H., Mackenzie, J. S., Hall, R. A., Deubel, V. & Gould, E. A. (2002). Phylogeny and molecular epidemiology of West Nile and Kunjin viruses. Curr Top Microbiol Immunol 267, 373-390.
35. Schlesinger, J. J., Brandriss, M. W. & Walsh, E. E. (1985). Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol 135, 2805-2809.
36. Shirato, K., Miyoshi, H., Goto, A., Ako, Y., Lleki, T., Kariwa, H. & Takashima, I. (2004). Viral envelope protein glycosylation is a molecular determinant of the neutoinvasiveness of the New York strain of West Nile virus. J Gen Virol 85, 3637-3645.
37. + cells in control of West Nile virus infection. J Virol 78, 8312-8321.
38. Smithburn, K. C., Hughes, T. P., Burke, A. W. & Paul, J. H. (1940). A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 20, 471-492.
39. Wengler, G., Castle, E., Leidner, U., Nowak, T. & Wengler, G. (1985). Sequence analysis of the membrane protein V3 of the flavivirus West Nile virus and of its gene. Virology 147, 264-267.
40. Yamshchikov, V. F., Wengler, G., Perelygin, A. A., Brinton, M. A. & Compans, R. W. (2001). An infectious clone of the West Nile flavivirus. Virology 281, 294-304.
41. Yamshchikov, G., Borisevich, V., Seregin, A., Chaporgina, E., Mishina, M., Mishin, V., Kwok, C. W. & Yamshchikov, V. (2004). An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: A candidate for live WN vaccine development. Virology 330, 304-312.